Amazon launches six-month $6 prescriptions to Prime members

The new benefit program follows Walmart's announcement and seeks to disrupt the prescription drug market.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Amazon (NASDAQ: AMZN) announced today that it is launching a new prescription program for members of its Prime loyalty program, less than a day after Walmart (NYSE: WMT) said it was offering Walmart+ members a discounted prescription service as well.

Having acquired PillPack in 2018, Amazon has been looking to leverage its ability to buy prescription medicine in bulk and provide savings to members in a bid to take a large slice of the $360 billion prescription drug market.

Like the Walmart program, Amazon's new service is looking for patients who take just a small number of fairly common medicines, such as those used to treat high blood pressure and diabetes; they'll pay as little as $1 per month and receive a six-month supply.

Six months is typically longer than what insurance companies will pay for, so consumers could see real savings by enrolling in the healthcare prescription program. As Prime members, they'd also be entitled to receive free two-day delivery.

The new offer is an expansion of the Amazon Pharmacy benefit announced last month that allows Prime members to comparison shop for savings through its network of 60,000 pharmacies. It noted Prime members save 80% on generic medications and 40% on name-brand ones through Amazon Pharmacy.

Walmart just introduced Walmart+ RX, which also provides significant discounts on commonly used medications. It notes that members of Walmart+, a loyalty program the retailer launched to challenge Amazon Prime, can get some common medications free while saving up to 85% on others.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Rich Duprey has no position in any of the stocks mentioned. John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Amazon. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. The Motley Fool Australia has recommended Amazon. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on International Stock News

Blue electric vehicle on a green rising arrow with a charger hanging out.
International Stock News

Boom! Why has Tesla stock rocketed 68% so far in 2023?

It's already been a year to remember for the electric vehicle giant.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
International Stock News

How an AI demo erased $140 billion from Alphabet stock

One error made this a costly display of Alphabet's new technology.

Read more »

A man with a beard and wearing dark sunglasses and a beanie head covering raises a fist in happy celebration as he sits at is computer in a home environment.
Share Market News

Meta stock price rockets 19% on $56 billion buyback

Meta stock has just seen one of its biggest jumps in history...

Read more »

woman looking surprised watching netflix
International Stock News

The Netflix share price just popped. Here's one way to buy in on the ASX

Here's one way to get a slice of whatever future Netflix might have.

Read more »

A futuristic view of electric vehicle technology with speeding bright light trails indicating power.
International Stock News

If I'd bought $5,000 of Tesla stock 3 years ago, what would my investment be worth now?

Here's how much mind-blowing money investors have made on Tesla stock in three years...

Read more »

A man and a woman sit in front of a laptop looking fascinated and captivated.
International Stock News

Alphabet stock: A once-in-a-decade opportunity to outdo Warren Buffett?

Is now the time to snap up shares in the global tech giant?

Read more »

Piggy bank on an electric charger.
International Stock News

Aussie investors are buying Tesla shares in droves. Should you?

A beaten-up stock, dramatic price cuts, and a controversial leader -- does investing in Tesla still make sense?

Read more »

Happy woman on her phone while her electric vehicle charges.
International Stock News

Should I buy Tesla stock for 2023 or not?

Is it finally time to buy Tesla stock?

Read more »